Twitter account of pharmaceutical executive Shkreli hacked

Before you go, we thought you'd like these...
Before you go close icon
Martin Shkreli's Twitter Gets Hacked

Martin Shkreli, the pharmaceutical executive facing U.S. charges of securities fraud, lost control of his Twitter account to hackers on Sunday, hours after he took to Twitter to plead his innocence, his spokesman said.

"It was hacked," Craig Stevens, a spokesman for the former chief executive of Turing Pharmaceuticals, said in an email. "We have been working with Twitter to get it fixed."

SEE ALSO: Martin Shkreli says securities fraud charges are 'baseless'

Shkreli, who gained notoriety this year when Turing hiked the price of an anti-infective drug often taken by people with AIDS, was arrested on fraud charges on Thursday and released on bail. He has actively defended his business practices on Twitter, tweeting as recently as Saturday that the allegations against him were "baseless."

Stevens said he was checking whether Shkreli's YouTube live stream, which he had been broadcasting from a day after leaving jail, had also been hacked.

A series of seven tweets at midday EST on Sunday from Shkreli's account included: "Anyone want free money? Willing to donate hundreds of thousands to charities before I go to prison ..."

Another read: "I am now a god", while as others contained expletives.

A Twitter spokesman said the company does not comment on individual accounts for privacy and security reasons. YouTube representatives did not immediately respond to a request for comment.

Shkreli stepped down as CEO of Turing, the company said on Friday, a day after he was charged with securities fraud, securities fraud conspiracy and wire fraud conspiracy related to his management of hedge fund MSMB Capital Management and biopharmaceutical company Retrophin Inc. The maximum sentence for the top count is 20 years in prison.

See photos from Shkreli's arrest:

6 PHOTOS
Martin Shkreli arrested
See Gallery
Twitter account of pharmaceutical executive Shkreli hacked
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is belted into an awaiting car after being taken into custody following a securities probe, on Thursday, Dec. 17, 2015 in New York. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, sits in an awaiting car after being taken into custody following a securities probe, on Thursday, Dec. 17, 2015 in New York. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York Thursday, Dec. 17, 2015, after being taken into custody following a securities probe. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York Thursday, Dec. 17, 2015, after being taken into custody following a securities probe. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)
Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York Thursday, Dec. 17, 2015, after being taken into custody following a securities probe. A seven-count indictment unsealed in Brooklyn federal court Thursday charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. (AP Photo/Craig Ruttle)
of
SEE ALL
BACK TO SLIDE
SHOW CAPTION +
HIDE CAPTION

The government charges do not include activities at privately held Turing.

Turing had incited outrage over drug prices earlier this year after it raised the price of the drug Daraprim to $750 a tablet from $13.50.

More on AOL.com:
Turing Pharma names chairman to replace Shkreli as CEO
Martin Shkreli arrested in securities fraud probe
It looks like Martin Shkreli could have his $2 million Wu-Tang album taken away

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners